Earnings per share was $0.85 in this quarter compared to $0.90 last year.
For the fourth quarter, total company net sales were $226.9 million, a decrease of 12% compared to the $257.7 million delivered in the same quarter last year.
After adjusting for the impact of foreign currency revaluation gains and losses, restructuring expenses, pension curtailment charges and expenses associated with the CirComp acquisition and integration, adjusted earnings per share was $0.89 this quarter compared to $0.97 last year.
As a result, our absolute leverage ratio declined from 0.89 at the end of Q3 to 0.74 at the end of Q4.
At the total company level, we are providing initial 2021 guidance as follows: revenue of between $850 million and $890 million; effective income tax rate of 28% to 30%; depreciation and amortization of between $70 million and $75 million; capital expenditures in the range of $50 million to $60 million; GAAP and adjusted earnings per share of between $2.40 and $2.80; and adjusted EBITDA of between $195 million and $220 million.
At the total company level, we are providing initial 2021 guidance as follows: revenue of between $850 million and $890 million; effective income tax rate of 28% to 30%; depreciation and amortization of between $70 million and $75 million; capital expenditures in the range of $50 million to $60 million; GAAP and adjusted earnings per share of between $2.40 and $2.80; and adjusted EBITDA of between $195 million and $220 million.
At the total company level, we are providing initial 2021 guidance as follows: revenue of between $850 million and $890 million; effective income tax rate of 28% to 30%; depreciation and amortization of between $70 million and $75 million; capital expenditures in the range of $50 million to $60 million; GAAP and adjusted earnings per share of between $2.40 and $2.80; and adjusted EBITDA of between $195 million and $220 million.
